002399.SZ · 海普瑞
China A-shares · RS rating 47 · As of 2026-10-14
| Price | 9.47 CNY |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 47 / 60 / 55 / 36 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 26 / 37 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -6.2% |
| Distance from 52-week high | +24.6% |
| Market cap (USD) | $2.2B |